Skip to Content

Clear Future Intensive Spot Treatment

Dosage form: lotion
Ingredients: SALICYLIC ACID 2mg in 15mL
Labeler: Arbonne International, LLC
NDC Code: 42508-210

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Clear Future® Intensive Spot Treatment

Drug Facts

Active ingredient

Salicylic Acid 2%

Purpose

Acne Treatment

Uses
  • for the treatment of acne.
  • penetrates pores to reduce the number of acne pimples.
  • dries and helps clear up acne pimples and allows skin to heal.

Warnings

For external use only

When using this product
  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
  • avoid contact with eyes. If contact occurs, rinse thoroughly with water.

Stop use and ask a doctor if irritation or redness develops and lasts.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions
  • cleanse the skin thoroughly before applying this product.
  • cover the entire affected area with a thin layer one to three times daily.
  • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
  • if bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Other information

STORAGE: 55°F–85°F

Inactive ingredients

water, isopentyldiol, glyceryl stearate SE, glycerin, butyrospermum parkii (shea) butter, glyceryl behenate, myristyl myristate, propanediol, hamamelis virginiana (witch hazel) water, isostearic acid, alpha-glucan oligosaccharide, bakuchiol, polyglyceryl-4 caprate, argania spinosa kernel oil, camellia sinensis seed oil, sesamum indicum (sesame) seed oil, serenoa serrulata fruit extract, salix alba (willow) bark extract, calendula officinalis flower extract, salvia officinalis (sage) leaf extract, rhamnose, saccharide isomerate, beta-sitosterol, glucose, glucuronic acid, tocopherol, niacinamide, xanthan gum, tridecyl salicylate, isodecyl salicylate, myristyl laurate, acrylates/C10-30 alkyl acrylate crosspolymer, aminomethyl propanol, cetyl alcohol, caprylyl glycol, benzethonium chloride, benzoic acid, chlorphenesin, phenoxyethanol.

Questions or comments?

1.800.272.6663

Monday–Friday
6 a.m.–6 p.m. Pacific time

Distributed by
Arbonne International, LLC
9400 Jeronimo Road
Irvine, CA 92618 USA

PRINCIPAL DISPLAY PANEL - 15 mL Tube Carton

ARBONNE®

CLEAR
FUTURE®

INTENSIVE ACNE
SPOT TREATMENT

SALICYLIC ACID 2%

0.5 fl. oz. / 15 mL

CLEAR FUTURE INTENSIVE SPOT TREATMENT 
salicylic acid lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:42508-210
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (SALICYLIC ACID) SALICYLIC ACID2 mg  in 15 mL
Inactive Ingredients
Ingredient NameStrength
WATER 
ISOPENTYLDIOL 
GLYCERYL STEARATE SE 
GLYCERIN 
SHEA BUTTER 
GLYCERYL DIBEHENATE 
MYRISTYL MYRISTATE 
PROPANEDIOL 
HAMAMELIS VIRGINIANA TOP WATER 
ISOSTEARIC ACID 
.ALPHA.-GLUCAN OLIGOSACCHARIDE 
BAKUCHIOL 
POLYGLYCERYL-4 CAPRATE 
ARGAN OIL 
CAMELLIA SINENSIS SEED OIL 
SESAME OIL 
SAW PALMETTO 
SALIX ALBA BARK 
CALENDULA OFFICINALIS FLOWER 
SAGE 
RHAMNOSE 
SACCHARIDE ISOMERATE 
.BETA.-SITOSTEROL 
DEXTROSE, UNSPECIFIED FORM 
GLUCURONIC ACID 
TOCOPHEROL 
NIACINAMIDE 
XANTHAN GUM 
TRIDECYL SALICYLATE 
ISODECYL SALICYLATE 
MYRISTYL LAURATE 
CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED) 
AMINOMETHYLPROPANOL 
CETYL ALCOHOL 
CAPRYLYL GLYCOL 
BENZETHONIUM CHLORIDE 
BENZOIC ACID 
CHLORPHENESIN 
PHENOXYETHANOL 
Packaging
#Item CodePackage Description
1NDC:42508-210-091 TUBE in 1 CARTON
115 mL in 1 TUBE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart333D04/01/2015
Labeler - Arbonne International, LLC (021541164)

 
Arbonne International, LLC

Medically reviewed on Jan 2, 2018

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide